Search Results - "Knoepfli, Marina"

Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm by Richani, Mandy, Kolly, Philippe, Knoepfli, Marina, Herrmann, Evelyn, Zweifel, Martin, Tengg-Kobligk, Hendrik von, Candinas, Daniel, Dufour, Jean-François

“…AbstractBackground and aims. The Barcelona Clinic Liver Cancer (BCLC) staging system is the algorithm most widely used to manage patients with hepatocellular…”
Get full text

Factors affecting screening for hepatocellular carcinoma by Hasani, Farah Al, Knoepfli, Marina, Gemperli, Armin, Kollar, Attila, Banz, Vanessa, Kettenbach, Joachim, Jüni, Peter, Dufour, Jean-François

“…AbstractBackground and aim. Hepatocellular carcinoma (HCC) is a frequent cancer. Its prognosis is highly dependent on early diagnosis. Patients at risk for…”
Get full text

Stereotactic image‐guided microwave ablation of hepatocellular carcinoma using a computer‐assisted navigation system by Lachenmayer, Anja, Tinguely, Pascale, Maurer, Martin H., Frehner, Lorenz, Knöpfli, Marina, Peterhans, Matthias, Weber, Stefan, Dufour, Jean‐François, Candinas, Daniel, Banz, Vanessa

“…Background & Aims Ablation plays an important role in the treatment of hepatocellular carcinoma. Because image‐guided navigation technology has recently…”
Get full text

FACT‐Hep increases the accuracy of survival prediction in HCC patients when added to ECOG Performance Status by Gmür, Andrea, Kolly, Philippe, Knöpfli, Marina, Dufour, Jean‐François

“…Background and aim The Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a strong predictor of survival for patients with hepatocellular…”
Get full text

Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm by Richani, Mandy, Kolly, Philippe, Knoepfli, Marina, Herrmann, Evelyn, Zweifel, Martin, Tengg-Kobligk, Hendrik von, Candinas, Daniel, Dufour, Jean-François

“…The Barcelona Clinic Liver Cancer (BCLC) staging system is the algorithm most widely used to manage patients with hepatocellular carcinoma (HCC). We aimed to…”
Get full text

HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin by Helbling, Beat, Jochum, Wolfram, Stamenic, Ivan, Knöpfli, Marina, Cerny, Andreas, Borovicka, J, Gonvers, Jean-Jacques, Wilhelmi, Martin, Dinges, Sabine, Müllhaupt, Beat, Esteban, Alicia, Meyer-Wyss, Beat, Renner, Eberhard L

“…In patients with hepatitis C virus (HCV)-related advanced fibrosis/cirrhosis, 30% of sustained HCV clearance has been reported with pegylated interferon…”
Get full text

Passive immunoprophylaxis to prevent hepatitis B virus reccurence after orthotopic liver transplantation: comparison of ANTI-HBs plasma to commercial immune globuline preparations by Bihl, Florian, Knoepfli, Marina, Castelli, Damiano, Cerny, Andreas

Get full text

Passive immunoprophylaxis and liver transplantation by Bihl, Florian, Knoepfli, Marina, Castelli, Damiano, Cerny, Andreas

Get full text